|
In order to fortify the regulatory framework and stimulate innovation within India's medical technology sector, the National Institution for Transforming India (NITI) Aayog, the Indian Council of Medical Research (ICMR) and the Central Drugs Standard Control Organization (CDSCO) are poised to host the 2nd Regulatory Awareness & Experiential Learning Workshop. Dedicated to "In-Vitro Diagnostics (IVDs)," this workshop is scheduled to unveil its insights on February 27, 2024.
The workshop aims to empower medtech innovators and startups with the requisite knowledge and tools to navigate the intricate regulatory milieu governing medical devices. It also seeks to nurture innovation and safeguard patient well-being within India's dynamic medtech landscape.
Speaking on the significance of the workshop, Dr. Rajiv Bahl, secretary to the Department of Health Research (DHR) and Director General (DG), ICMR, emphasized the pivotal role of regulatory awareness in fostering a conducive ecosystem for medtech innovation. He stated, "The workshop serves as a crucial platform for medtech innovators to gain insights into regulatory compliance, industry best practices, and emerging trends in the realm of in-vitro diagnostics. By fostering collaboration between regulatory authorities and industry stakeholders, we aim to catalyze innovation, enhance patient safety, and drive the medtech sector towards unprecedented growth."
The event, set to take place at National Academy of Medical Sciences, New Delhi, will feature an illustrious lineup of speakers, including Dr. Rajeev Singh Raghuvanshi, Drugs Controller General of India (DCGI). Attendees can expect interactive sessions, illuminating discussions, and practical insights aimed at empowering them to navigate the regulatory landscape with confidence and competence.
The workshop will delve into key regulatory nuances, industry trends, and emerging best practices, offering attendees a holistic understanding of the regulatory ecosystem governing medical devices in India. Pioneering innovators in the field of in-vitro diagnostics will also share their experiences and insights, fostering a collaborative ecosystem where practical wisdom and innovative ideas converge to chart the course for transformative advancements.
The MedTech Mitra initiative aimed at fostering synergistic collaborations between regulatory authorities and industry stakeholders, will take center stage, catalyzing innovation, enhancing patient safety, and propelling the medtech sector towards unprecedented growth trajectories. Prospective participants have been urged to register for the workshop before the stipulated deadline of February 20, 2024, through the provided registration link.
|